Bayforest Capital’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
Other funds holding RLAY
Bayforest Capital's RLAY Position: Q3 2026 in Review
Bayforest Capital opened a new position in Relay Therapeutics (RLAY) in Q3 2026: 10,274 shares worth $185K. The stake represents 0.27% of the portfolio and ranks #65 among its holdings.
261 funds tracked by Wall St. Rank hold RLAY as of Q3 2026.
- Bayforest Capital held 10,274 shares of Relay Therapeutics worth $185K as of Q3 2026.
- Relay Therapeutics was a new Bayforest Capital position in Q3 2026.
- Relay Therapeutics made up 0.27% of Bayforest Capital's portfolio in Q3 2026, its #65 holding.
- 261 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2026.
Based on Bayforest Capital's 13F filing for Q3 2026, filed 3 Nov 2026.